These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7533826)

  • 21. Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret.
    Endo T; Minami M; Monma Y; Saito H; Takeuchi M
    J Toxicol Sci; 1990 Nov; 15(4):235-44. PubMed ID: 1707101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
    Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
    Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake.
    Joy T; Walsh G; Tokmakejian S; Van Uum SH
    Can J Gastroenterol; 2008 Jan; 22(1):49-53. PubMed ID: 18209781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis.
    du Bois A; Vach W; Wechsel U; Holy R; Schaefer W
    Br J Cancer; 1996 Oct; 74(7):1137-40. PubMed ID: 8855988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin-induced alterations of serotonin metabolism in patients with or without emesis following chemotherapy.
    Dubois A; Siebert C; Vach W; Kriesingerschroeder H
    Oncol Rep; 1995 Sep; 2(5):839-42. PubMed ID: 21597827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.
    Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G
    Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromogranin A correlates with norepinephrine release rate.
    Dimsdale JE; O'Connor DT; Ziegler M; Mills P
    Life Sci; 1992; 51(7):519-25. PubMed ID: 1640800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.
    Giampaolo B; Angelica M; Antonio S
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):41-50. PubMed ID: 12100068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
    Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
    Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.
    Darmani NA
    J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study.
    Taplin ME; George DJ; Halabi S; Sanford B; Febbo PG; Hennessy KT; Mihos CG; Vogelzang NJ; Small EJ; Kantoff PW
    Urology; 2005 Aug; 66(2):386-91. PubMed ID: 16098367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
    Navari RM; Reinhardt RR; Gralla RJ; Kris MG; Hesketh PJ; Khojasteh A; Kindler H; Grote TH; Pendergrass K; Grunberg SM; Carides AD; Gertz BJ
    N Engl J Med; 1999 Jan; 340(3):190-5. PubMed ID: 9917226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
    Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
    Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of elevated serum chromogranin A levels.
    Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
    Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoelectron microscopic study of the luminal release of chromogranin A from rat enterochromaffin cells.
    Okumiya K; Fujimiya M
    Histochem Cell Biol; 1999 Apr; 111(4):253-7. PubMed ID: 10219624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew.
    Darmani NA; McClanahan BA; Trinh C; Petrosino S; Valenti M; Di Marzo V
    Neuropharmacology; 2005 Sep; 49(4):502-13. PubMed ID: 15921709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat.
    Milano S; Simon C; Grélot L
    Clin Auton Res; 1991 Dec; 1(4):275-80. PubMed ID: 1822260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.